Researcher.Life Logo

Journal of Clinical Oncology : Impact Factor & More

eISSN: 1527-7755pISSN: 0732-183X

Aims and Scope of Journal of Clinical Oncology

The Journal of Clinical Oncology is a peer-reviewed medical journal published 3 times a month by the American Society of Clinical Oncology. It covers research on all aspects of clinical oncology. All articles older than one year are freely available online. The journal was established in 1983 and the editor-in-chief is Jonathan W. Friedberg. JCO's Impact Factor is 32.956 as reported by Clarivate in its 2019 Journal Citation Reports. Less

Key Metrics

CiteScore
40.9
Eigenfactor
0.1 - 0.5
Impact Factor
>= 25
Scite Index
0.87 5-Year SI
SJR
Q1Oncology
SNIP
6.97
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Journal of Clinical Oncology

Journal of Clinical Oncology Journal Specifications

Overview
Publisher LIPPINCOTT WILLIAMS & WILKINS
Language English
Frequency Fortnightly
General Details
LanguageEnglish
FrequencyFortnightly
Publication Start Year1983
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Journal of Clinical Oncology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Journal of Clinical Oncology

Are You Bereaved?
  • 25 Nov 2025
  • Journal of Clinical Oncology
Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trial.
  • 25 Nov 2025
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Reply to: Optimizing Control Arms in Chronic Lymphocytic Leukemia Clinical Trials: The BRUIN-CLL-321 Trial.
  • 21 Nov 2025
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Optimizing Control Arms in Chronic Lymphocytic Leukemia Clinical Trials: The BRUIN-CLL-321 Trial.
  • 21 Nov 2025
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Carboplatin for Premenopausal Triple-Negative Breast Cancer: Time to Rethink the Neoadjuvant Standard?
  • 21 Nov 2025
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
If Exercise Were a Pill, We'd All Prescribe It to Patients With Cancer. But It's Not.
  • 21 Nov 2025
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Are You Bereaved?
  • 25 Nov 2025
  • Journal of Clinical Oncology
Efficacy and Safety of Neoadjuvant TQB2102 in Locally Advanced or Early Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: A Randomized, Open-Label, Multicenter, Phase II Trial.
  • 25 Nov 2025
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Reply to: Optimizing Control Arms in Chronic Lymphocytic Leukemia Clinical Trials: The BRUIN-CLL-321 Trial.
  • 21 Nov 2025
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Optimizing Control Arms in Chronic Lymphocytic Leukemia Clinical Trials: The BRUIN-CLL-321 Trial.
  • 21 Nov 2025
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Carboplatin for Premenopausal Triple-Negative Breast Cancer: Time to Rethink the Neoadjuvant Standard?
  • 21 Nov 2025
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
If Exercise Were a Pill, We'd All Prescribe It to Patients With Cancer. But It's Not.
  • 21 Nov 2025
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology

FAQs on Journal of Clinical Oncology